每經AI快(kuai)訊(xun)，中科微至（SH 688211，收(shou)(shou)(shou)(shou)盤(pan)價：42.86元(yuan)(yuan)）2月27日晚間發(fa)(fa)布(bu)2022年(nian)度(du)(du)(du)業(ye)績快報，營(ying)業(ye)收(shou)(shou)(shou)(shou)入(ru)(ru)約(yue)(yue)23.14億元(yuan)(yuan)，同(tong)(tong)比(bi)增(zeng)加(jia)(jia)4.73%；歸屬于上市(shi)公(gong)(gong)司(si)(si)股東的(de)(de)(de)凈利潤虧損約(yue)(yue)1.16億元(yuan)(yuan)；基本每(mei)股收(shou)(shou)(shou)(shou)益(yi)虧損0.89元(yuan)(yuan)。期(qi)間費(fei)(fei)用影(ying)響報告期(qi)內，公(gong)(gong)司(si)(si)立足未(wei)(wei)來(lai)長(chang)遠(yuan)發(fa)(fa)展(zhan)，進一(yi)步加(jia)(jia)強了(le)高素質(zhi)人才團(tuan)隊的(de)(de)(de)建設，積極(ji)擴充(chong)了(le)管(guan)理、銷(xiao)售和(he)研(yan)發(fa)(fa)團(tuan)隊，也擴充(chong)了(le)海外業(ye)務(wu)的(de)(de)(de)銷(xiao)售和(he)售后服務(wu)團(tuan)隊等，公(gong)(gong)司(si)(si)員工(gong)人數增(zeng)加(jia)(jia)四百多人，工(gong)資薪酬同(tong)(tong)比(bi)增(zeng)長(chang)6500萬(wan)(wan)元(yuan)(yuan)左右。同(tong)(tong)時，公(gong)(gong)司(si)(si)持(chi)續(xu)(xu)重視(shi)研(yan)發(fa)(fa)投入(ru)(ru)，積極(ji)布(bu)局系列化(hua)產品(pin)線，其中研(yan)發(fa)(fa)測試(shi)材(cai)料及測試(shi)線搭建成(cheng)(cheng)(cheng)本同(tong)(tong)比(bi)增(zeng)加(jia)(jia)3900萬(wan)(wan)元(yuan)(yuan)左右，同(tong)(tong)比(bi)增(zeng)加(jia)(jia)約(yue)(yue)122個百分(fen)點(dian)。研(yan)發(fa)(fa)費(fei)(fei)用占營(ying)業(ye)收(shou)(shou)(shou)(shou)入(ru)(ru)比(bi)重約(yue)(yue)8.8%，同(tong)(tong)比(bi)增(zeng)加(jia)(jia)約(yue)(yue)2.7個百分(fen)點(dian)，高強度(du)(du)(du)的(de)(de)(de)研(yan)發(fa)(fa)投入(ru)(ru)為公(gong)(gong)司(si)(si)的(de)(de)(de)可持(chi)續(xu)(xu)發(fa)(fa)展(zhan)奠(dian)定基礎，更加(jia)(jia)有利于公(gong)(gong)司(si)(si)未(wei)(wei)來(lai)的(de)(de)(de)長(chang)期(qi)高質(zhi)量發(fa)(fa)展(zhan)。信(xin)用減(jian)值損失影(ying)響受(shou)疫(yi)情(qing)影(ying)響，公(gong)(gong)司(si)(si)無法進入(ru)(ru)客戶現場直(zhi)接溝通回(hui)(hui)款(kuan)事宜，應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)催(cui)(cui)款(kuan)受(shou)阻，公(gong)(gong)司(si)(si)2021年(nian)第四季度(du)(du)(du)形成(cheng)(cheng)(cheng)的(de)(de)(de)應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)約(yue)(yue)2.9億元(yuan)(yuan)在2022年(nian)未(wei)(wei)及時收(shou)(shou)(shou)(shou)回(hui)(hui)，轉為1至2年(nian)賬(zhang)齡的(de)(de)(de)應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)，計(ji)提壞(huai)賬(zhang)比(bi)例從5%增(zeng)長(chang)到30%，對(dui)應(ying)(ying)的(de)(de)(de)壞(huai)賬(zhang)計(ji)提金(jin)額增(zeng)長(chang)7250萬(wan)(wan)元(yuan)(yuan)左右。2022年(nian)末疫(yi)情(qing)管(guan)控放開，公(gong)(gong)司(si)(si)已(yi)第一(yi)時間組織力量催(cui)(cui)收(shou)(shou)(shou)(shou)應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)。截至目前(qian)應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)已(yi)收(shou)(shou)(shou)(shou)回(hui)(hui)約(yue)(yue)3.96億元(yuan)(yuan)，對(dui)應(ying)(ying)壞(huai)賬(zhang)計(ji)提金(jin)額6700萬(wan)(wan)元(yuan)(yuan)，公(gong)(gong)司(si)(si)預計(ji)大部分(fen)應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)后續(xu)(xu)可以(yi)(yi)收(shou)(shou)(shou)(shou)回(hui)(hui)，不(bu)會(hui)形成(cheng)(cheng)(cheng)實質(zhi)性的(de)(de)(de)壞(huai)賬(zhang)。以(yi)(yi)上所表(biao)述的(de)(de)(de)數據將以(yi)(yi)公(gong)(gong)司(si)(si)披露的(de)(de)(de)經審計(ji)的(de)(de)(de)2022年(nian)年(nian)度(du)(du)(du)報告為準(zhun)。產品(pin)售價下(xia)調，毛利率同(tong)(tong)比(bi)下(xia)降(jiang)13個百分(fen)點(dian)。研(yan)發(fa)(fa)投入(ru)(ru)加(jia)(jia)大，研(yan)發(fa)(fa)測試(shi)材(cai)料及測試(shi)線搭建成(cheng)(cheng)(cheng)本同(tong)(tong)比(bi)增(zeng)加(jia)(jia)3900萬(wan)(wan)元(yuan)(yuan)左右。期(qi)間費(fei)(fei)用增(zeng)長(chang)，工(gong)資薪酬同(tong)(tong)比(bi)增(zeng)加(jia)(jia)約(yue)(yue)6500萬(wan)(wan)元(yuan)(yuan)。受(shou)疫(yi)情(qing)影(ying)響，應(ying)(ying)收(shou)(shou)(shou)(shou)賬(zhang)款(kuan)催(cui)(cui)款(kuan)受(shou)阻，信(xin)用減(jian)值損失同(tong)(tong)比(bi)增(zeng)加(jia)(jia)約(yue)(yue)5000萬(wan)(wan)元(yuan)(yuan)。

2022年(nian)1至(zhi)6月份(fen)，中科(ke)微至(zhi)的營業(ye)收(shou)入(ru)構成(cheng)為：交(jiao)叉帶分(fen)揀系(xi)(xi)(xi)統占(zhan)比(bi)45.69%，總集成(cheng)式分(fen)揀系(xi)(xi)(xi)統占(zhan)比(bi)28.58%，大件分(fen)揀系(xi)(xi)(xi)統占(zhan)比(bi)11.59%，其他(ta)業(ye)務占(zhan)比(bi)5.78%，單件分(fen)離占(zhan)比(bi)4.96%。

中科微(wei)至的董(dong)事長是(shi)李功(gong)燕，男(nan)(nan)，44歲，學歷背景為(wei)博(bo)士；總經理是(shi)姚益，男(nan)(nan)，36歲，學歷背景為(wei)碩(shuo)士。

截至發稿，中科微至市值為56億元(yuan)。

道達(da)號（daoda1997）“個股趨勢”提醒(xing)：
1. 近30日內無機構對中科微至進行調研。
更(geng)多個(ge)股趨勢信息，請搜索微信公眾(zhong)號“道達號”，回復“查詢”，領取免費查詢權限！

每經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲明：本(ben)文內容(rong)與(yu)數(shu)據僅供參考，不構成投資(zi)建議，使用前請(qing)核實。據此操(cao)作，風(feng)險(xian)自擔。